Company intelligence / Profile preview

ENEA Tech e Biomedical

Rome, Lazio, Italy

Ownership: Private
Employees: ~11
Development stage: Other

Overview

ENEA Tech e Biomedical Foundation is an active technology transfer and biomedical investment fund established by Italy's Ministry of Enterprise and Made in Italy, supporting drug, vaccine, diagnostic device, and digital health innovation via equity investment in small and medium-sized enterprises, innovative startups, and co-investment partnerships[1][3][5][7][9].

Therapeutic areas: OncologyOther
Modalities: Small moleculeBiologicVaccineDiagnostic deviceDigital health solutionAI-based medical softwareNanoparticle (for diagnostics)Exosome-based therapy
Industry: Investors

Partnerships

Ministry of Enterprise and Made in Italy (MIMIT - fund stewardship)Genextra (via Tethis investment)Indaco Venture Partners (via Tethis investment)Frequent co-investment with Italian startups, academic spin-offs, other VC funds, public/private entities

Beyond the preview

Go deeper on ENEA Tech e Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENEA Tech e Biomedical.

Explore the full profile